跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALHEMO concizumab 300 mg / 3 mL solution for injection prefilled pen - TGA Drug Approval Details
Approvals
/
TGA
/
ALHEMO concizumab 300 mg / 3 mL solution for injection prefilled pen
Approved
STANDARD
ALHEMO concizumab 300 mg / 3 mL solution for injection prefilled pen
Novo Nordisk Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
d6ec00d1857f111a
Company
Novo Nordisk Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
d6ec00d1857f111a
Product Name
ALHEMO concizumab 300 mg / 3 mL solution for injection prefilled pen
Artg Id
394066
Artg Name
ALHEMO concizumab 300 mg / 3 mL solution for injection prefilled pen
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path
/organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date
2023-07-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
d6ec00d1857f111a
Type
Standard
Back to TGA Approvals